Antimicrobial Agents and Chemotherapy · 1984 · 123 citations · 1 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceBeta-lactam ResistanceCombination Antimicrobial TherapyActivitiesAmoxicillin TherapyBacterial Infection TreatmentBeta-lactamase InhibitorsBeta-lactamase Mediated ResistanceResistance In Clinical IsolatesTreatment Of Bacterial Resistanceβ-Lactam Antibiotics
YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.
1